Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HIV funding for Africa

Executive Summary

President Bush's proposed $500 mil. "International Mother & Child HIV Prevention Initiative" would fund administration of combination HIV therapy for pregnant women in the second trimester, continuing for both mother and child after birth, in countries with "adequate infrastructure." In other nations, goal would be administration of a single dose of nevirapine (Boehringer Ingelheim's Viramune) to the mother shortly before delivery and at least one dose to the child immediately after birth...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS040049

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel